Eligibility Prostate Cancer NCT00953225

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
male veterans (> 18 years of age) recently diagnosed with low-risk pca (histologically documented adenocarcinoma of the prostate)
Beschreibung

ID.1

Datentyp

boolean

a serum psa value of up to 10.0 ng/ml, and a gleason score of six or less (three or less in either architectural pattern)
Beschreibung

ID.2

Datentyp

boolean

for the purpose of eligibility, these additional criteria will be verified: *serum creatinine 2.0 mg/dl
Beschreibung

ID.3

Datentyp

boolean

serum phosphate (measured as phosphorus) > 2.3 and < 4.8 mg/dl
Beschreibung

ID.4

Datentyp

boolean

serum calcium > 8.5 and < 10.5 mg/dl
Beschreibung

ID.5

Datentyp

boolean

Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
subjects with any concurrent malignancy, except non-melanoma skin cancer
Beschreibung

ID.6

Datentyp

boolean

subjects with a history of sarcoidosis
Beschreibung

ID.7

Datentyp

boolean

subjects with a history of high-dose (1,000 iu per day) vitamin d supplementation
Beschreibung

ID.8

Datentyp

boolean

subjects with a history of hypercalcemia
Beschreibung

ID.9

Datentyp

boolean

subjects who use lithium as a medication
Beschreibung

ID.10

Datentyp

boolean

Ähnliche Modelle

Eligibility Prostate Cancer NCT00953225

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
male veterans (> 18 years of age) recently diagnosed with low-risk pca (histologically documented adenocarcinoma of the prostate)
boolean
ID.2
Item
a serum psa value of up to 10.0 ng/ml, and a gleason score of six or less (three or less in either architectural pattern)
boolean
ID.3
Item
for the purpose of eligibility, these additional criteria will be verified: *serum creatinine 2.0 mg/dl
boolean
ID.4
Item
serum phosphate (measured as phosphorus) > 2.3 and < 4.8 mg/dl
boolean
ID.5
Item
serum calcium > 8.5 and < 10.5 mg/dl
boolean
Item Group
C0680251 (UMLS CUI)
ID.6
Item
subjects with any concurrent malignancy, except non-melanoma skin cancer
boolean
ID.7
Item
subjects with a history of sarcoidosis
boolean
ID.8
Item
subjects with a history of high-dose (1,000 iu per day) vitamin d supplementation
boolean
ID.9
Item
subjects with a history of hypercalcemia
boolean
ID.10
Item
subjects who use lithium as a medication
boolean